Etiology and Outcome of Inflammatory Bowel Disease Tender - 16716898

Procurement Summary

Country: Dominican Republic

Summary: Etiology and Outcome of Inflammatory Bowel Disease

Deadline: 30 Sep 2017

Posting Date: 23 Sep 2017

Other Information

Notice Type: Tender

TOT Ref.No.: 16716898

Document Ref. No.: RFA-DP- 18-001

Competition: ICB

Financier: Self Financed

Purchaser Ownership: -

Tender Value: Refer Document

CPV Classification

33600000 - Pharmaceutical products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Tenders are invited for Etiology and Outcome of Inflammatory Bowel Disease
Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is characterized by chronic inflammation of gastrointestinal tract. In 2015, approximately three million US adults reported having a diagnosis of IBD and the estimated number has increased greatly from 1.8 million since 1999. While the exact cause is unknown, the severity and progression of the disease largely impacts the patients’ quality of life and imposes huge financial burden to the US healthcare system. The purpose of this announcement is to 1) establish a new IBD registry to estimate incidence of IBD in the adult and pediatric populations and extrapolate to the US population; 2) describe the natural history and outcomes of IBD; 3) determine racial/ethnic variation in the detection and management of IBD; and 4) identify evidence-based strategies to improve disease outcomes. The results are anticipated to enhance understanding of the impact of IBD on the overall health of affected persons and the impact of various clinical practices and healthcare delivery approaches on the disease outcomes.
Estimated Total Program Funding: $3, 250, 000

Award Ceiling: $800, 000

Documents

 Tender Notice